Investment banker Barclays announced it has initiated coverage of 20 U.S.
Get ready, bargain shoppers. Foamix (FOMX) has plummeted 27% since the beginning of the year and it looks like the stock received more …
This week turned out to be a nightmare for shareholders of Catalyst Pharmaceuticals (CPRX), as the stock price plummeted nearly 55%. What’s causing …
Anti-cholesterol drugmaker Amarin (AMRN) reported a better-than-expected $0.07-per-share loss on Wednesday on $73.
Zogenix (ZGNX) is one of the pharma’s biggest losers today. The reason?
With primary care clinicians playing an ever-increasing role in the management of diabetes, staying on top of new developments in the American Diabetes …
Do you have high cholesterol? Investors in Amarin (AMRN) kind of hope that you do — but ideally, not too high.
It’s a short and dramatic plunge for Biogen (BIIB) stock. Today, the biotech giant’s shares lost 29% of their value and reached levels …
It’s a very rewarding trading day for investors in Spark Therapeutics (ONCE) with shares skyrocketing 120%, making the stock Wall Street’s bull of …
Bausch Health (BHC) saw its shares crater by as much as 10% today on exceptionally high volume. This drop was triggered by the release …
